An Australian Doctor’s Dream: Curing America’s Opioid Curse [The New York Times]
BIOCORRX INC NEW (BICX)
NASDAQ:AMEX Investor Relations:
ir.biocorrx.com
Company Research
Source: The New York Times
An Australian Doctor’s Dream: Curing America’s Opioid Curse - The New York Times ment Supported by An Australian Doctor’s Dream: Curing America’s Opioid Curse By Isabella Kwai June 6, SUBIACO, Australia — The hazy-eyed sheep shearer was shifting in his seat in a clinic in Western Australia, unsure if he could do what the doctor said would save his life. A heroin user for 20 years, he was now in the depths of a detoxification treatment. “I’m all alone,” he said. In a soft voice, the doctor, George O’Neil, pleaded with the man to continue to the next stage: an implant of the drug naltrexone, a device that the physician himself had invented and that is an emerging facet of an impassioned debate over the best way to treat addiction. “I don’t win with everybody,” the doctor said after the man had left. “But I try.” Over almost two decades, Dr. O’Neil, 70, has implanted his device — which is unlicensed but legal in Australia — into thousands of people who have ed to his nonprofit clinic in
Show less
Read more
Impact Snapshot
Event Time:
BICX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BICX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BICX alerts
High impacting BIOCORRX INC NEW news events
Weekly update
A roundup of the hottest topics
BICX
News
- BioCorRx Pharmaceuticals Inc. Awarded New Patent for Novel Compound to Treat Pain, Depression, and Schizophrenia [Yahoo! Finance]Yahoo! Finance
- BioCorRx Pharmaceuticals Inc. Awarded New Patent for Novel Compound to Treat Pain, Depression, and SchizophreniaGlobeNewswire
- BioCorRx Reports Business Update for 2023 [Yahoo! Finance]Yahoo! Finance
- BioCorRx Reports Business Update for 2023GlobeNewswire
- BioCorRx Pharmaceuticals Inc. Awarded NIDA Grant of Approximately $11 million Over Three Years for Research on BICX104, a Naltrexone Implant in Combination with Bupropion for the Treatment of MUD [Yahoo! Finance]Yahoo! Finance
BICX
Sec Filings
- 5/1/24 - Form 4
- 4/5/24 - Form 4
- 4/3/24 - Form 8-K
- BICX's page on the SEC website